A method for preparing an N-substituted glutarimide compound
By carrying out a cyclization coupling reaction under a protective atmosphere and using a titanium dichlorocerocatalyst, N-substituted glutarimides can be synthesized under mild conditions. This overcomes the limitations of existing techniques for synthesizing polysubstituted glutarimides, achieving highly selective and high-yield compound synthesis, which is suitable for the development of pharmaceuticals and organic functional materials.
Patent Information
- Application Number
- CN202511412098.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-29
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies have limitations in synthesizing multi-substituted or highly functionalized N-substituted glutarimides, including the use of strong acid-base reagents and complex protecting group operations, making it difficult to meet the structural diversity requirements of modern drug design.
A one-step synthesis method was adopted, in which tertiary α-haloamide compounds, electron-withdrawing olefins, catalysts and magnesium powder were carried out in an organic solvent under a protective atmosphere. Dichlorodicyclopentadiene or CpTiCl3 was used as the catalyst, and the reaction was carried out at ≤40℃ to avoid high-temperature side reactions.
This method enables the synthesis of N-substituted glutarimide compounds with high selectivity and high yield, expands the applicable range of reaction substrates, reduces experimental costs and operational risks, and is applicable to a variety of substrates, making it widely applicable.
Smart Images

Figure BDA0005621599940000011 
Figure BDA0005621599940000021 
Figure BDA0005621599940000031
Abstract
Description
Technical Field
[0001] This invention relates to the field of organic synthesis technology, and specifically to a method for preparing N-substituted glutarimide compounds. Background Technology
[0002] N-substituted glutarimides are an important class of six-membered heterocyclic compounds with wide applications in medicinal chemistry and organic synthesis. The core structure of N-substituted glutarimides—the 2,6-piperidinidone skeleton—is found in many commercially available drugs, such as the sedative-hypnotic drug thalidomide, the antitumor drug migrastatin, and the antipsychotic drug cinperene. These compounds have attracted considerable attention due to their diverse biological activities (such as antitumor, anti-inflammatory, and neuromodulation), especially as ligands for E3 ubiquitin ligases in protein degradation chimeric structures (PROTACs), further expanding their pharmaceutical potential. From a chemical perspective, glutarimide derivatives, due to their unique structure, can participate in a variety of reactions and are important intermediates for constructing complex heterocyclic systems and functionalized molecules.
[0003] Traditional synthetic methods for N-substituted glutarimides involve the condensation reaction of acid anhydrides or dicarboxylic acid derivatives with primary amines. However, these methods have limitations in synthesizing polysubstituted or highly functionalized glutarimides, including the use of strong acid-base reagents and the manipulation of complex protecting groups, making it difficult to meet the structural diversity requirements of modern drug design. Therefore, developing more efficient and selective synthetic methods for N-substituted glutarimides to expand structural diversity and bioactivity remains a key research focus. Summary of the Invention
[0004] In view of this, the object of the present invention is to provide a method for preparing N-substituted glutarimide compounds. The preparation method provided by the present invention has a wide range of applicable reaction substrates, high product selectivity, and high yield.
[0005] To achieve the above-mentioned objectives, the present invention provides the following technical solution:
[0006] This invention provides a method for preparing N-substituted glutarimide compounds, comprising the following steps:
[0007] Under a protective atmosphere, a tertiary α-haloamide compound, an electron-withdrawing olefin, a catalyst, magnesium powder, and an organic solvent are mixed and subjected to a cyclization coupling reaction to obtain an N-substituted glutarimide compound; the catalyst includes one or more of dichlorodicyclopentadiene, CpTiCl3, and Cp*TiCl3; the temperature of the cyclization coupling reaction is ≤40℃.
[0008] Preferably, the tertiary α-haloamide has the structure shown in Formula I:
[0009]
[0010] Among them, R 1 R 2 and R 3 Independently, it is alkyl, alkenyl, cycloalkyl, unsubstituted or substituted aryl, and X is chlorine or bromine.
[0011] Preferably, the alkyl group includes C1 to C4 alkyl groups;
[0012] The alkenyl group includes C4-C18 alkenyl groups;
[0013] The cycloalkyl group includes C3 to C10 cycloalkyl groups;
[0014] The aryl groups in the unsubstituted or substituted aryl groups include phenyl, naphthyl, tetrahydropyranyl, thiophenyl, piperidinyl, pyridinyl, furanyl, indolyl, or dehydroabiyl.
[0015] The substituents in the substituted aryl group include one or more of alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, cyano, phenyl, alkylamine, alkynyl, alkenyl, and Boc protecting groups.
[0016] Preferably, the R 1 Including methyl, ethyl, isopropyl, cyclobutane, cyclopentane, cycloheptane or 2-bicyclo[2.2.1]heptane;
[0017] The R 2 Including methyl, phenyl, 2-methylphenyl, cyclobutane, cyclopentane, cycloheptane or 2-bicyclo[2.2.1]heptane;
[0018] The R 3 This includes residues in primary amines other than -NH2; said primary amines include benzylamine, 2-(trifluoromethyl)benzylamine, o-chlorobenzylamine, o-methylbenzylamine, m-methylbenzylamine, p-trifluoromethoxybenzylamine, p-bromobenzylamine, p-chlorobenzylamine, p-cyanobenzylamine, p-phenylbenzylamine, 3,4-methylenedioxybenzylamine, alpha-methylbenzylamine, aniline, mesitylene, 2-naphthylamine, butylamine, cyclopentylmethylamine, cyclohexylmethylamine, 1-adamantanemethylamine, 4-aminotetrahydropyran, 2-thiopheneethylamine, 2-methylallylamine, cyclopropylamine, 4-ethynylaniline, 1-Boc-4-aminopiperidine, 2-amino-5-cyanopyridine, 1,3-phenylenediamine, methylamine, 2-furan-2-ylethylamine, tryptamine, oleylamine, dehydrorosinamine, naproxen, or amlodipine.
[0019] Preferably, the electron-withdrawing olefin includes substituted phenyl acrylate;
[0020] The substituted phenyl acrylates have the structure shown in Formula II:
[0021]
[0022] Among them, R 4 R is an alkyl or substituted phenyl group. 5 It is a phenyl or substituted phenyl.
[0023] Preferably, the alkyl group includes C1 to C4 alkyl groups;
[0024] The substituents in the substituted phenyl group include methylene, methyl, or trifluoromethyl.
[0025] Preferably, the molar ratio of the tertiary α-haloamide compound to the electron-withdrawing olefin is 1:1 to 3.
[0026] Preferably, the molar ratio of the tertiary α-haloamide compound to the catalyst is 1:0.05 to 0.2.
[0027] Preferably, the molar ratio of the tertiary α-haloamide compound to magnesium powder is 1:1 to 3.
[0028] Preferably, the cyclization coupling reaction takes 3 to 24 hours.
[0029] This invention employs a one-step synthesis method with mild reaction conditions, reacting in titanium dichlorophenoxyacetate, magnesium powder, and organic solvents. This avoids side reactions that may be caused by high temperatures, resulting in high product yields. Furthermore, the preparation method provided by this invention is tolerant to heat-sensitive functional groups, increasing the applicability of reaction substrates; it reduces the need for specialized equipment (such as high-temperature and high-pressure reactors), lowering experimental costs and operational risks. The preparation method provided by this invention is simple to operate, low in cost, and applicable to a variety of substrates, demonstrating wide applicability.
[0030] The preparation method provided by this invention does not require the addition of expensive ligands that are difficult to synthesize. Under relatively mild conditions, it can achieve highly chemoselective cyclization coupling reactions between N-substituted glutarimide compounds and electron-withdrawing alkenes, yielding a series of sterically hindered N-substituted glutarimides that are difficult to synthesize using conventional methods. This provides guidance for enriching the synthetic methods of N-substituted glutarimide compounds. The N-substituted glutarimide compounds synthesized using this method can be further functionalized to obtain various compounds, which can be applied to the development and research of pharmaceuticals and organic functional materials. Detailed Implementation
[0031] This invention provides a method for preparing N-substituted glutarimide compounds, comprising the following steps: under a protective atmosphere, mixing a tertiary α-haloamide compound, an electron-withdrawing olefin, a catalyst, magnesium powder, and an organic solvent, and carrying out a cyclization coupling reaction to obtain an N-substituted glutarimide compound; the catalyst includes one or more of dichlorodicyclopentadiene, CpTiCl3, and Cp*TiCl3; the temperature of the cyclization coupling reaction is ≤40℃.
[0032] Unless otherwise specified, the materials and equipment used in this invention are all commercially available products in the field.
[0033] In this invention, the tertiary α-haloamide can have the structure shown in Formula I:
[0034]
[0035] Among them, R 1 R 2 and R 3 Independently, it can be alkyl, alkenyl, cycloalkyl, unsubstituted or substituted aryl, where X is chlorine or bromine.
[0036] In this invention, the alkyl group may include C1 to C4 alkyl groups, specifically methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl or tert-butyl.
[0037] In this invention, the alkenyl group may include C4 to C18 alkenyl groups, specifically C4 alkenyl, C5 alkenyl, C6 alkenyl, C7 alkenyl, C8 alkenyl, C9 alkenyl, C10 alkenyl, C11 alkenyl, C12 alkenyl, C13 alkenyl, C14 alkenyl, C15 alkenyl, C16 alkenyl, C17 alkenyl, or C18 alkenyl; the C4 alkenyl group may include 2-methylallyl.
[0038] In this invention, the cycloalkyl group may include C3 to C10 cycloalkyl groups, specifically C3 cycloalkyl, C4 cycloalkyl, C5 cycloalkyl, C6 cycloalkyl, C7 cycloalkyl, C8 cycloalkyl, C9 cycloalkyl or C10 cycloalkyl; the C9 cycloalkyl group may include 2-bicyclo[2.2.1]heptyl; the C10 cycloalkyl group may include adamantyl.
[0039] In this invention, the aryl group in the unsubstituted or substituted aryl group may include phenyl, naphthyl, tetrahydropyranyl, thiophene, piperidinyl, pyridinyl, furanyl, indolyl, or dehydroabiyl. In this invention, the substituent in the substituted aryl group may include one or more of alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, cyano, phenyl, alkylamine, alkynyl, alkenyl, and Boc protecting group; the alkyl group includes C1-C4 alkyl, specifically methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl; the alkoxy group may include C1-C4 alkoxy, specifically methoxy, ethoxy, propoxy, or butoxy; the halogen in the haloalkyl group may include fluorine, chlorine, bromine, or iodine. The alkyl group in the alkyl group includes C1-C4 alkyl groups, which may specifically be methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl; the halogen in the haloalkoxy group may include fluorine, chlorine, bromine, or iodine, and the alkoxy group in the haloalkoxy group may include C1-C4 alkoxy groups, which may specifically be methoxy, ethoxy, propoxy, or butoxy; the halogen may include fluorine, chlorine, bromine, or iodine; the alkyl group in the alkylamine group includes C1-C4 alkyl groups, which may specifically be methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl.
[0040] In this invention, the R 1 It may include methyl, ethyl, isopropyl, cyclobutane, cyclopentane, cycloheptane or 2-bicyclo[2.2.1]heptane.
[0041] In this invention, the R 2 It may include methyl, phenyl, 2-methylphenyl, cyclobutane, cyclopentane, cycloheptane or 2-bicyclo[2.2.1]heptane.
[0042] In this invention, the R 3 It may include residues other than -NH2 in a primary amine; the primary amine may include benzylamine, 2-(trifluoromethyl)benzylamine, o-chlorobenzylamine, o-methylbenzylamine, m-methylbenzylamine, p-trifluoromethoxybenzylamine, p-bromobenzylamine, p-chlorobenzylamine, p-cyanobenzylamine, p-phenylbenzylamine, 3,4-methylenedioxybenzylamine, alpha-methylbenzylamine, aniline, mesitylene, 2-naphthylamine, butylamine, cyclopentylmethylamine, cyclohexylmethylamine, 1-adamantanemethylamine, 4-aminotetrahydropyran, 2-thiopheneethylamine, 2-methylallylamine, cyclopropylamine, 4-ethynylaniline, 1-Boc-4-aminopiperidine, 2-amino-5-cyanopyridine, 1,3-phenylenediamine, methylamine, 2-furan-2-ylethylamine, tryptamine, oleylamine, dehydrorosinamine, naproxen, or amlodipine.
[0043] In this invention, the tertiary α-haloamide compound may have any one of the structures shown in 1a~1z and 1aa~1ap:
[0044]
[0045]
[0046] In this invention, the electron-withdrawing olefin may include substituted phenyl acrylates, which may have the structure shown in Formula II:
[0047]
[0048] Among them, R 4 R is an alkyl or substituted phenyl group. 5 The alkyl group is a phenyl or substituted phenyl group. In this invention, the alkyl group may include C1-C4 alkyl groups, specifically methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl. In this invention, the substituent in the substituted phenyl group may include methylene, methyl, or trifluoromethyl. In this invention, the R... 4 It may include methyl, ethyl, phenyl, benzyl, 2-methylphenyl, 3-methylphenyl, or 4-CF3-phenyl. In this invention, the R... 5 It may include phenyl or 4-CF3-phenyl.
[0049] In this invention, the electron-withdrawing olefin may have the structure shown in any one of 2a to 2j:
[0050]
[0051] In this invention, the molar ratio of the tertiary α-haloamide compound to the electron-withdrawing olefin can be 1:1 to 3, or 1:1.5 to 2.5, specifically 1:1, 1:1.2, 1:1.5, 1:1.8, 1:2, 1:2.2, 1:2.5, 1:2.8 or 1:3.
[0052] In this invention, the molar ratio of the tertiary α-haloamide compound to the catalyst can be 1:0.05–0.2, or 1:0.1–0.15, specifically 1:0.05, 1:0.08, 1:0.1, 1:0.12, 1:0.15, 1:0.18, or 1:0.2. In this invention, the catalyst includes one or more of titanium dichlorophenocene, CpTiCl3, and Cp*TiCl3, specifically titanium dichlorophenocene.
[0053] In this invention, the molar ratio of the tertiary α-haloamide compound to magnesium powder can be 1:1 to 3, or 1:1.5 to 2.5, specifically 1:1, 1:1.2, 1:1.5, 1:1.8, 1:2, 1:2.2, 1:2.5, 1:2.8 or 1:3.
[0054] In this invention, the protective atmosphere may include nitrogen, helium or argon; the pressure of the protective atmosphere may be atmospheric pressure.
[0055] In this invention, the organic solvent may include one or more of tetrahydrofuran, ethylene glycol dimethyl ether, 2-methyltetrahydrofuran, and acetonitrile. This invention does not have a particular limitation on the amount of the organic solvent used, as long as it is sufficient to ensure the smooth progress of the cyclization coupling reaction.
[0056] In this invention, the temperature of the cyclization coupling reaction is ≤40℃, and can be 20~40℃, specifically 20℃, 25℃, 30℃, 35℃, or 40℃; the time of the cyclization coupling reaction can be 3~24h, or 5~15h, specifically 3h, 5h, 8h, 10h, 12h, 15h, 18h, 20h, 22h, or 24h; the cyclization coupling reaction can be carried out under stirring conditions; the cyclization coupling reaction can be carried out in a pressure-resistant tube. In this invention, the reaction formula for the cyclization coupling reaction is as follows:
[0057]
[0058] After completing the cyclization coupling reaction, the present invention may further include: purifying the reaction solution obtained from the cyclization coupling reaction by column chromatography to obtain N-substituted glutarimide compounds. In the present invention, the eluent used for column chromatography purification may include petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate may be 10:1 to 1:1, specifically 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, or 1:1.
[0059] To further illustrate the present invention, the preparation method of the N-substituted glutarimide compounds provided by the present invention is described in detail below with reference to the embodiments, but these should not be construed as limiting the scope of protection of the present invention.
[0060] Example 1
[0061] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dioxide dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3a, with a yield of 83%.
[0062] The chemical reaction formula for the above preparation process is as follows:
[0063]
[0064] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.41-7.36(m,2H),7.31-7.20(m,6H),7.03-6.96(m,2H),5.11(d,J=13.7 Hz,1H),4.97(d,J=13.7Hz,1H),2.70-2.57(m,1H),2.46-2.30(m,2H),2.16-2.02(m,1H),1.54(s,3H). 13 C NMR (101MHz, CDCl3) δ175.9,172.2,141.1,137.2,129.1,129.0,128.4,127.5,127.4,125.6,47.8,43.4,30.6,30.2,27.7.HRMS(ESI)m / z:[M+H] + calcd for C 19 H 20 NO2 + :294.1489; found:294.1493.
[0065] Example 2
[0066] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1b, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3b, with a yield of 58%.
[0067] The chemical reaction formula for the above preparation process is as follows:
[0068]
[0069] The structural characterization data are as follows: 1H NMR(400MHz,Chloroform-d)δ7.68(dd,J=7.7,1.5Hz,1H),7.42-7.29(m,5H),7.19(d,J=6.9Hz,2H),6.86(d,J=7.6Hz,1H ),5.30(d,J=16.0Hz,1H),5.23(d,J=16.0Hz,1H),2.83-2.73(m,1H),2.67-2.51(m,2H),2.30-2.19(m,1H),1.59(s,3H). 13 C NMR(101MHz, CDCl3)δ175.6,172.3,140.3,135.3,131.8,129.2,127.7,126.9,125.9,125.7,47.9,40.4,40.3,30.2,30.1,28.3.HRMS(ESI)m / z:[M+H] + calcd forC 20 H 19 F3NO2 + :362.1362; found:362.1354.
[0070] Example 3
[0071] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1c, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3c, with a yield of 78%.
[0072] The chemical reaction formula for the above preparation process is as follows:
[0073]
[0074] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.39-7.26(m,4H),7.21-7.12(m,4H),6.92(dd,J=7.4,1.9Hz,1H), 5.17(d,1H),5.16(d,1H),2.78-2.69(m,1H),2.61-2.44(m,2H),2.26-2.16(m,1H),1.58(s,3H). 13C NMR (101MHz, CDCl3) δ175.7,172.2,140.6,134.2,133.2,129.6,129.1,128 .3,127.6,126.6,125.7,48.0,41.3,30.4,30.2,28.1.HRMS(ESI)m / z:[M+H] + calcd for C 19 H 19 ClNO2 + :328.1099; found:328.1102.
[0075] Example 4
[0076] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1d, 0.2 mmol, 57.4 mg), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3d, with a yield of 80%.
[0077] The chemical reaction formula for the above preparation process is as follows:
[0078]
[0079] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.33-7.25(m,3H),7.17-7.14(m,2H),7.13-7.07(m,3H),6.92(d,J=7.5Hz,1H),5.10(d,J= 14.8Hz,1H),4.99(d,J=14.8Hz,1H),2.76-2.67(m,1H),2.57-2.44(m,2H),2.42(s,3H),2.23-2.13(m,1H),1.57(s,3H). 13 C NMR (101MHz, CDCl3) δ175.9,172.4,140.8,135.9,134.9,130.3,129.1,127.0, 126.4,125.9,125.7,47.9,40.8,30.5,30.3,28.0,19.4.HRMS(ESI)m / z:[M+Na] + calcd forC 20 H 21 NNaO2+ 330.1464; found: 330.1477.
[0080] Example 5
[0081] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1e, 0.2 mmol, 57.4 mg), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3e, with a yield of 82%.
[0082] The chemical reaction formula for the above preparation process is as follows:
[0083]
[0084] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.28-7.21(m,3H),7.20-7.15(m,3H),7.10-7.00(m,3H),5.07(d,J=13.7Hz,1H),4.95( d,J=13.7Hz,1H),2.70-2.60(m,1H),2.48-2.34(m,2H),2.32(s,3H),2.11(td,J=14.2,13.6,4.7Hz,1H),1.56(s,3H). 13 CNMR(101MHz,CDCl3)δ175.9,172.3,141.1,138.0,137.0,129.5,129.0,128.3,12 8.2,127.4,126.0,125.6,47.8,43.4,30.6,30.2,27.8,21.4.HRMS(ESI)m / z:[M+H] + calcd forC 20 H 22 NO2 + :308.1645; found:308.1662.
[0085] Example 6
[0086] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1f, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3f, with a yield of 68%.
[0087] The chemical reaction formula for the above preparation process is as follows:
[0088]
[0089] The structural characterization data are as follows: 1 HNMR(400MHz,Chloroform-d)δ7.44(d,J=8.6Hz,2H),7.22(t,3H),7.15(d,J=8.1Hz,2H),6.99-6.93(m,2H),5.10 (d,J=13.7Hz,1H),4.96(d,J=13.7Hz,1H),2.71-2.61(m,1H),2.49-2.34(m,2H),2.18-2.07(m,1H),1.55(s,3H). 13 C NMR (101MHz, CDCl3) δ175.9,172.2,148.5,140.8,135.8,130.8,129.0,127.5,125.4,120.9,47.7,42.6,30.4,30.2,27.7. 19 F NMR (376MHz, CDCl3) δ -57.8.
[0090] Example 7
[0091] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1 g, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3 g, with a yield of 65%.
[0092] The chemical reaction formula for the above preparation process is as follows:
[0093]
[0094] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.43(d,J=8.4Hz,2H),7.31-7.23(m,5H),7.01-6.98(m,2H),5.04(d,J=13 .7Hz,1H),4.92(d,J=13.7Hz,1H),2.70-2.60(m,1H),2.47-2.34(m,2H),2.15-2.04(m,1H),1.55(s,3H). 13 C NMR (101MHz, CDCl3) δ175.9,172.2,140.9,136.1,131.5,131.0,129.1,127.5,125.5,121.5,47.7,42.8,30.5,30.2,27.7.HRMS(ESI)m / z:[M+Na] + calcd for C 19 H 18 BrNNaO2 + :394.0413; found:396.0396.
[0095] Example 8
[0096] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1h, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3h, with a yield of 85%.
[0097] The chemical reaction formula for the above preparation process is as follows:
[0098]
[0099] The structural characterization data are as follows: 1 HNMR(400MHz,Chloroform-d)δ7.34(d,J=8.4Hz,2H),7.29-7.22(m,5H),7.02-6.97(m,2H),5.05(d,J=13 .7Hz,1H),4.93(d,J=13.7Hz,1H),2.68-2.60(m,1H),2.46-2.34(m,2H),2.15-2.05(m,1H),1.55(s,3H). 13C NMR (101MHz, CDCl3) δ175.9,172.2,140.9,135.6,133.4,130.7,129.1,128.5,127.5,125.5,47.7,42.8,30.5,30.2,27.7.HRMS(ESI)m / z:[M+Na] + calcd for C 19 H 18 ClNNaO2 + :350.0918; found:350.0931.
[0100] Example 9
[0101] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1i, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3i, with a yield of 80%.
[0102] The chemical reaction formula for the above preparation process is as follows:
[0103]
[0104] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.60(d,J=8.3Hz,2H),7.47(d,J=8.2Hz,2H),7.29-7.24(m,3H),7.03-6.98(m,2H),5. 12(d,J=14.0Hz,1H),5.01(d,J=14.0Hz,1H),2.74-2.63(m,1H),2.51-2.38(m,2H),2.18-2.07(m,1H),1.56(s,3H). 13 CNMR(101MHz,CDCl3)δ175.9,172.2,142.4,140.6,132.3,129.7,129.1,127 .6,125.4,118.8,111.4,47.8,43.1,30.3,30.1,27.8.HRMS(ESI)m / z:[M+Na] + calcd for C 20 H 18 N2NaO2 +:341.1260; found:341.1267.
[0105] Example 10
[0106] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1j, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3j, with a yield of 77%.
[0107] The chemical reaction formula for the above preparation process is as follows:
[0108]
[0109] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.59(d,2H),7.54(d,2H),7.45(q,4H),7.35(t,1H),7.26-7.19(m,3H),7.02(dd, 2H),5.15(d,J=13.7Hz,1H),5.02(d,J=13.7Hz,1H),2.66(m,1H),2.49-2.35(m,2H),2.12(m,1H),1.57(s,3H). 13 C NMR (101MHz, CDCl3) δ176.0,172.3,141.0,140.9,140.4,136.2,129.6,129.0,128.8,1 27.4,127.3,127.1,125.6,47.8,43.2,30.6,30.2,27.8.HRMS(ESI)m / z:[M+Na]+calcd forC25H23NNaO2+:392.1621; found:392.1636.
[0110] Example 11
[0111] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1k, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3k, with a yield of 74%.
[0112] The chemical reaction formula for the above preparation process is as follows:
[0113]
[0114] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.31-7.18(m,3H),7.07-6.98(m,2H),6.96-6.88(m,2H),6.76-6.73(m,1H),5.93(s,2H),5.0 0(d,J=13.6Hz,1H),4.89(d,J=13.6Hz,1H),2.68-2.59(m,1H),2.44-2.32(m,2H),2.15-2.05(m,1H),1.56(s,3H). 13 C NMR (101MHz, CDCl3) δ176.0,172.2,147.5,146.9,141.1,131.0,129.0,127.4,125. 6,122.9,109.9,108.1,101.0,47.8,43.2,30.6,30.2,27.7.HRMS(ESI)m / z:[M+Na] + calcd forC 25 H 23 NNaO2 + 360.1206; found: 360.1208.
[0115] Example 12
[0116] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1l, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in Formula 3l, with a yield of 75% (3:2 d.r).
[0117] The chemical reaction formula for the above preparation process is as follows:
[0118]
[0119] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.39-7.27(m,6H),7.22-7.20(m,3H),6.92-6.83(m,1H),6.19-6.09(m,1H),2. 69-2.55(m,1H),2.49-2.32(m,2H),2.16-2.04(m,1H),1.82(d,J=7.1Hz,3H),1.49(d,J=4.3Hz,3H). 13 C NMR (101MHz, CDCl3) δ175.74,175.72,172.4,141.3,141.0,140.9,140.1,129.1,129.0,128.1,127.9,127.7,127.4,127.3, 127.1,127.0,126.9,125.6,125.6,50.1,50.0,48.1,48.1,30.7,30.6,30.2,30.1,28.04,28.02,16.3.HRMS(ESI)m / z:[M+H] + calcd for C 20 H 22 NO2 + :308.1645; found:308.1647.
[0120] Example 13
[0121] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1m, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3m, with a yield of 80%.
[0122] The chemical reaction formula for the above preparation process is as follows:
[0123]
[0124] The structural characterization data are as follows: 1HNMR(400MHz, CDCl3)δ7.48(t,2H),7.40(t,3H),7.34-7.29(m,3H),7.12(d ,2H),2.81-2.72(m,1H),2.62-2.48(m,2H),2.36-2.24(m,1H),1.61(s,3H). 13 CNMR(101MHz, CDCl3)δ176.0,172.4,140.9,135.8,129.4,129.3,128.6,128.4,127.7,125.6,48.2,30.4,28.0.HRMS(ESI)m / z:[M+H] + calcd for C 18 H 18 NO2 + :280.1332; found:280.1332.
[0125] Example 14
[0126] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1n, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dioxide dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3n, with a yield of 61%.
[0127] The chemical reaction formula for the above preparation process is as follows:
[0128]
[0129] The structural characterization data are as follows: 1 H NMR(400MHz, CDCl3)δ7.39(d,4H),7.31(h,1H),6.95(s,2H),2.87-2.79(m,1H),2.78-2.68(m, 1H),2.65-2.57(m,1H),2.29(s,3H),2.28-2.19(m,1H),2.05(s,3H),1.95(s,3H),1.64(s,3H). 13C NMR (101MHz, CDCl3) δ175.2,171.8,140.5,138.4,135.2,134.5,131.2,129.5,129.3 ,129.1,127.6,125.9,48.2,30.7,30.5,28.7,21.1,17.9,17.7.HRMS(ESI)m / z:[M+H] + calcd for C 21 H 24 NO2 + :322.1802; found:322.1814.
[0130] Example 15
[0131] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1o, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3o, with a yield of 77%.
[0132] The chemical reaction formula for the above preparation process is as follows:
[0133]
[0134] The structural characterization data are as follows: 1 H NMR (400MHz, Chloroform-d) δ7.94 (d, J = 8.6Hz, 1H), 7.90-7.82 (m, 2H), 7.63 (s, 1H), 7.54-7.47 (m, 2H), 7.46-7. 40(m,2H),7.38-7.31(m,3H),7.21(t,1H),2.84-2.76(m,1H),2.67-2.50(m,2H),2.38-2.28(m,1H),1.63(s,3H). 13 C NMR (101MHz, CDCl3) δ176.2,172.6,140.9,133.6,133.2,133.1,129.4,129.3,128.2,127.9 ,127.7,127.4,126.7,126.5,126.0,125.6,48.2,30.51,30.49,28.1.HRMS(ESI)m / z:[M+Na] + calcdfor C 22 H19 NNaO2 + :352.1308; found:352.1313.
[0135] Example 16
[0136] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1p, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3p, with a yield of 54%.
[0137] The chemical reaction formula for the above preparation process is as follows:
[0138]
[0139] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.37-7.31(m,2H),7.29-7.26(m,1H),7.20-7.16(m,2H),3.91-3.77(m,2H),2.65-2.56(m,1H ),2.44-2.32(m,2H),2.15-2.04(m,1H),1.57(s,3H),1.55-1.48(m,2H),1.39-1.31(m,2H),0.95(t,J=7.4Hz,3H). 13 C NMR (101MHz, CDCl3) δ176.0,172.3,141.3,129.1,127.4,125.6,47.8,40.2,30.8,30.2,30.0,27.9,20.3,13.8.HRMS(ESI)m / z:[M+Na] + calcd for C 16 H 21 NNaO2 + :282.1464; found:282.1468.
[0140] Example 17
[0141] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1q, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3q, with a yield of 61%.
[0142] The chemical reaction formula for the above preparation process is as follows:
[0143]
[0144] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.37-7.31(m,2H),7.29-7.24(m,1H),7.22-7.18(m,2H),3.85(dd,J=7.6,1.1Hz,2H),2.61(t d,1H),2.45-2.34(m,2H),2.30(p,1H),2.09(td,1H),1.77-1.61(m,4H),1.58(s,3H),1.56-1.47(m,2H),1.35-1.19(m,2H). 13 C NMR(101MHz, CDCl3)δ176.3,172.6,141.3,129.0,127.4,125.6,47.9,44.5,38.7,30.8,30.4,30.28,30.25,28.0,24.91,24.89.HRMS(ESI)m / z:[M+Na] + calcd forC 18 H 23 NNaO2 + 308.1621; found: 308.1630.
[0145] Example 18
[0146] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1r, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3r, with a yield of 67%.
[0147] The chemical reaction formula for the above preparation process is as follows:
[0148]
[0149] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.34(t,2H),7.27(t,1H),7.19(d,2H),3.73(d,2H),2.62(m,1H),2.46-2.34(m ,2H),2.09(m,1H),1.76-1.62(m,5H),1.57(s,3H),1.56-1.49(m,1H),1.27-1.12(m,3H),1.07-0.93(m,2H). 13 C NMR (101MHz, CDCl3) δ176.3,172.6,141.2,129.0,127.4,125.6,47.9,45.9, 36.4,30.9,30.8,30.7,30.2,28.1,26.4,25.9,25.8.HRMS(ESI)m / z:[M+Na] + calcd for C 19 H 25 NNaO2 + :322.1777; found:322.1787.
[0150] Example 19
[0151] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1s, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3s, with a yield of 84%.
[0152] The chemical reaction formula for the above preparation process is as follows:
[0153]
[0154] The structural characterization data are as follows: 1H NMR (400MHz, CDCl3) δ7.36-7.31(m,2H),7.29-7.25(m,1H),7.25-7.17(m,2H),3.70(d,2H),2.71-2.63(m,1H),2. 48-2.31(m,2H),2.11(m,1H),1.95(m,3H),1.72-1.62(m,5H),1.61(s,3H),1.60-1.57(m,1H),1.56-1.46(m,6H). 13 C NMR (101MHz, CDCl3) δ176.8,173.0,141.3,129.0,127.4,125.8,50.0,48.3,41.2,36.9,35.5,30.6,30.3,28.4.HRMS(ESI)m / z:[M+Na] + calcd forC 23 H 29 NNaO2 + :374.2090; found:374.2103.
[0155] Example 20
[0156] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1t, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3t, with a yield of 56%.
[0157] The chemical reaction formula for the above preparation process is as follows:
[0158]
[0159] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.37-7.32(m,2H),7.30-7.24(m,1H),7.20-7.16(m,2H),4.94-4.82(m,1H),4.12-4.00( m,2H),3.46(t,2H),2.82-2.55(m,3H),2.46-2.31(m,2H),2.16-2.04(m,1H),1.55(s,3H),1.54-1.42(m,2H). 13C NMR (101MHz, CDCl3) δ176.4,172.6,141.3,129.1,127.5,125.4,68.1,68.0,50.6,48.3,30.8,30.3,29.7,28.9,28.1.HRMS(ESI)m / z:[M+Na] + calcd for C 25 H 23 NNaO2 + :310.1414; found:310.1415.
[0160] Example 21
[0161] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1u, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3u, with a yield of 41%.
[0162] The chemical reaction formula for the above preparation process is as follows:
[0163]
[0164] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.33(t,J=7.4Hz,2H),7.29-7.25(m,1H),7.17-7.13(m,3H),6.96-6.93(m,1H),6.87(d,J= 2.8Hz,1H),4.24-4.06(m,2H),3.19-3.04(m,2H),2.63-2.55(m,1H),2.44-2.31(m,2H),2.12-2.02(m,1H),1.56(s,3H). 13 C NMR(101MHz, CDCl3)δ175.9,172.1,141.1,140.6,129.1,127.4,126.9,125.6,125.6,123.9,47.9,41.3,30.8,30.1,28.0,27.8.HRMS(ESI)m / z:[M+H] + calcd forC 18 H 20 NO2S +:314.1215; found:314.1226.
[0165] Example 22
[0166] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1v, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3v, with a yield of 56%.
[0167] The chemical reaction formula for the above preparation process is as follows:
[0168]
[0169] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.31-7.22(m,8H),7.20-7.17(m,2H),5.04(d,J=14.0Hz,1H),4.94(d,J=13.9Hz,1H),2.7 8-2.69(m,1H),2.64(m,1H),2.48(m,1H),2.38-2.29(m,1H),2.20(m,1H),0.93(d,J=6.7Hz,3H),0.69(d,J=7.0Hz,3H). 13 C NMR (101MHz, CDCl3) δ174.7,172.0,137.5,137.2,128.7,128.5,128.3,127.4 ,127.2,126.9,54.3,43.3,37.0,29.8,20.3,19.2,16.8.HRMS(ESI)m / z:[M+H] + calcd forC 21 H 24 NO2 + :322.1802; found:322.1801.
[0170] Example 23
[0171] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1w, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3w, with a yield of 52%.
[0172] The chemical reaction formula for the above preparation process is as follows:
[0173]
[0174] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.37-7.32(m,2H),7.32-7.21(m,6H),7.07-7.02(m,2H),5.10(d,J=13.8Hz,1H),4. 96(d,J=13.8Hz,1H),2.68(m,1H),2.48(m,1H),2.32(m,1H),2.20(m,1H),2.06(m,1H),1.88(m,1H),0.84(t,3H). 13 C NMR(101MHz, CDCl3)δ175.1,172.2,139.4,137.2,128.9,128.8,128.3,127.4,127.4,126.2,51.5,43.3,33.7,30.0,25.9,9.2.HRMS(ESI)m / z:[M+Na] + calcd for C 20 H 21 NNaO2 + :330.1464; found:330.1472.
[0175] Example 24
[0176] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1x, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3x, with a yield of 78%.
[0177] The chemical reaction formula for the above preparation process is as follows:
[0178]
[0179] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.39(d,2H),7.34-7.24(m,3H),7.03(d,2H),6.88(d,2H),5.10(d,J=13.7Hz, 1H), 4.97 (d, J = 13.7Hz, 1H), 2.63 (m, 1H), 2.48-2.34 (m, 2H), 2.29 (s, 3H), 2.09 (m, 3.8Hz, 1H), 1.53 (s, 3H). 13 C NMR(101MHz, CDCl3)δ176.1,172.3,138.0,137.2,137.1,129.7,129.1,128.4,127.5,125.4,47.4,43.4,30.6,30.2,27.8,20.9.HRMS(ESI)m / z:[M+Na] + calcd forC 20 H 21 NNaO2 + 330.1464; found: 330.1476.
[0180] Example 25
[0181] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1y, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3y, with a yield of 48%.
[0182] The chemical reaction formula for the above preparation process is as follows:
[0183]
[0184] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.32-7.20(m,5H),4.94(s,2H),2.73(t,J=6.8Hz,2H),1.80(t,J=6.8Hz,2H),1.27(s,6H). 13C NMR(101MHz, CDCl3)δ178.0,172.1,137.5,128.5,128.4,127.3,43.1,38.4,30.9,29.7,25.5.HRMS(ESI)m / z:[M+Na] + calcdfor C 14 H 17 NNaO2 + :254.1151; found:254.1151.
[0185] Example 26
[0186] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1z, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3z, with a yield of 67%.
[0187] The chemical reaction formula for the above preparation process is as follows:
[0188]
[0189] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ4.79(hept,1H),4.56(hept,1H),4.30(s,2H),2.75(t,J=6.8Hz,2H),1.84(t,J=6.8Hz,2H),1.73(s,3H),1.30(s,6H). 13 C NMR(101MHz, CDCl3)δ177.7,172.0,140.0,109.5,44.5,38.5,31.0,29.6,25.6,20.6.HRMS(ESI)m / z:[M+H] + calcd for C 16 H 20 NO2 + :258.1489; found:258.1496.
[0190] Example 27
[0191] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1aa, 0.2 mmol, 32.2 mg), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3aa, with a yield of 67%.
[0192] The chemical reaction formula for the above preparation process is as follows:
[0193]
[0194] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ2.66(t,J=6.8Hz,2H),2.54-2.44(m,1H),1.77(t,J=6.8Hz,2H),1.25(s,6H),1.11-0.97(m,2H),0.60-0.49(m,2H). 13 C NMR(101MHz, CDCl3)δ179.2,173.3,38.8,31.0,30.1,25.5,24.0,8.3.HRMS(ESI)m / z:[M+H] + calcd for C 10 H 16 NO2 + :182.1176; found:182.1176.
[0195] Example 28
[0196] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ab, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ab, with a yield of 56%.
[0197] The chemical reaction formula for the above preparation process is as follows:
[0198]
[0199] The structural characterization data are as follows: 1H NMR (400MHz, CDCl3) δ7.53-7.45(m,2H),6.99-6.91(m,2H),3.02(s,1H),2.79(t,J=6.8Hz,2H),1.88(t,J=6.8Hz,2H),1.30(s,6H). 13 C NMR (101MHz, CDCl3) δ177.9,172.1,136.0,133.0,128.6,122.4,82.9,78.0,38.8,31.0,29.9,25.4.HRMS(ESI)m / z:[M+H] + calcd for C 15 H 16 NO2 + :242.1176; found:242.1176.
[0200] Example 29
[0201] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ac, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 2:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ac, with a yield of 66%.
[0202] The chemical reaction formula for the above preparation process is as follows:
[0203]
[0204] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ4.59 (m, 1H), 4.26-4.02 (m, 2H), 2.61 (t, J = 6.8Hz, 4H), 2.43 -2.28(m,2H),1.71(t,J=6.8Hz,2H),1.39(s,9H),1.38-1.33(m,2H),1.18(s,6H). 13 C NMR (101MHz, CDCl3) δ178.5,172.5,154.6,79.4,51.4,39.0,30.8,30.3,28.4,28.2,25.6.
[0205] Example 30
[0206] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ad, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.4 mmol), titanium dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 3:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ad, with a yield of 59%.
[0207] The chemical reaction formula for the above preparation process is as follows:
[0208]
[0209] The structural characterization data are as follows: 1 HNMR (400MHz, CDCl3) δ8.82 (dd, J=2.3, 0.8Hz, 1H), 8.02 (dd, J=8.2, 2.2Hz, 1H), 7.2 2(dd,J=8.2,0.8Hz,1H),2.82(t,J=6.8Hz,2H),1.93(t,J=6.8Hz,2H),1.33(s,6H). 13 C NMR(101MHz, CDCl3)δ177.7,171.9,153.1,152.6,141.4,124.5,115.9,110.1,38.8,31.0,29.7,25.2.HRMS(ESI)m / z:[M+Na] + calcd forC 13 H 13 N3NaO2 + :266.0900; found:266.0913.
[0210] Example 31
[0211] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ae, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 2:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ae, with a yield of 32%.
[0212] The chemical reaction formula for the above preparation process is as follows:
[0213]
[0214] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.23-7.11(m,4H),4.90(s,4H),2.73(t,J=6.8Hz,4H),1.82(t,J=6.8Hz,4H),1.28(s,12H). 13 C NMR(101MHz, CDCl3)δ177.9,172.1,137.5,128.5,127.7,127.1,42.9,38.4,30.9,29.7,25.5.HRMS(ESI)m / z:[M+Na] + calcd for C 22 H 28 N2NaO4 + :407.1941; found:407.1941.
[0215] Example 32
[0216] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1af, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3af, with a yield of 55%.
[0217] The chemical reaction formula for the above preparation process is as follows:
[0218]
[0219] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ3.13(s,3H),2.72(t,J=6.8Hz,2H),1.81(t,J=6.8Hz,2H),1.28(s,6H). 13 C NMR(101MHz, CDCl3)δ178.3,172.5,38.4,31.0,29.6,26.9,25.6.HRMS(ESI)m / z:[M+H] + calcd for C8H 14 NO2 + :156.1019; found:156.1018.
[0220] Example 33
[0221] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1 ag, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3 ag, with a yield of 59%.
[0222] The chemical reaction formula for the above preparation process is as follows:
[0223]
[0224] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.34-7.20(m,5H),4.94(s,2H),2.66(t,2H),2.61-2.48(m,2H),2.14-1.95(m,4H),1.94-1.84(m,2H). 13 CNMR(101MHz, CDCl3)δ176.4,172.2,137.5,128.5,128.4,127.3,43.6,43.0,29.6,29.3,28.7,15.4.HRMS(ESI)m / z:[M+Na] + calcd for C 15 H 17 NNaO2 + :266.1151; found:266.1151.
[0225] Example 34
[0226] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ah, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ah, with a yield of 49%.
[0227] The chemical reaction formula for the above preparation process is as follows:
[0228]
[0229] The structural characterization data are as follows: 1H NMR (400MHz, CDCl3) δ7.34-7.19 (m, 5H), 4.95 (s, 2H), 2.71 (t, J = 6.7Hz, 2H), 2.17-2.09(m,2H),1.88-1.76(m,4H),1.75-1.65(m,2H),1.60-1.51(m,2H). 13 C NMR(101MHz, CDCl3)δ178.3,172.4,137.6,128.5,128.4,127.3,49.2,43.1,36.9,30.6,29.7,25.5.HRMS(ESI)m / z:[M+Na] + calcd for C 16 H 19 NNaO2 + :280.1308; found:280.1316.
[0230] Example 35
[0231] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ai, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ai, with a yield of 75%.
[0232] The chemical reaction formula for the above preparation process is as follows:
[0233]
[0234] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.25-7.12(m,5H),4.86(s,2H),2.61(t,J=6.8Hz,2H),2.05-1.94 (m,2H),1.75(t,J=6.8Hz,2H),1.68-1.59(m,2H),1.58-1.49(m,2H),1.49-1.31(m,6H). 13 C NMR (101MHz, CDCl3)δ
[0235] 178.7172.1,137.6,128.4,128.4,127.2,44.4,43.1,36.3,30.5,29.2,29.1,23.0.HRMS(ESI)m / z:[M+Na] + calcd for C 18 H 23 NNaO2 + 308.1621; found: 308.1623.
[0236] Example 36
[0237] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1aj, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3aj, with a yield of 65%.
[0238] The chemical reaction formula for the above preparation process is as follows:
[0239]
[0240] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.28-7.14(m,5H),4.89(d,2H),2.84-2.72(m,1H),2.66-2.57(m,1H),2.29-2.20(m,2H),2.13(dd ,1H),1.80-1.67(m,2H),1.57-1.54(m,1H),1.43-1.29(m,2H),1.25-1.16(m,2H),1.11-1.05(m,1H),0.99-0.87(m,1H). 13 CNMR(101MHz, CDCl3)δ176.1,172.5,137.7,128.6,128.3,127.2,50.1,43.5,41.7,41.0,38.2,37.0,30.5,29.1,27.6,25.2.HRMS(ESI)m / z:[M+Na]+calcd for C18H21NNaO2+:306.1465; found:306.1466.
[0241] Example 37
[0242] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ak, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ak, with a yield of 63%.
[0243] The chemical reaction formula for the above preparation process is as follows:
[0244]
[0245] The structural characterization data are as follows: 1 H NMR(400MHz,Chloroform-d)δ7.34(dd,J=1.7,1.0Hz,1H),7.30-7.20(m,3H),7.10-7.01(m,2H),6. 38-6.29(m,2H),5.07(s,2H),2.69-2.60(m,1H),2.45-2.31(m,2H),2.19-2.04(m,1H),1.57(s,3H). 13 C NMR (101MHz, CDCl3) δ175.6,171.8,150.4,141.9,141.1,129.1,127.4,125.5,110.3,109.1,47.9,36.2,30.7,30.1,27.6.HRMS(ESI)m / z:[M+Na] + calcd for C 17 H 17 NNaO3 + 306.1101; found: 306.1118.
[0246] Example 38
[0247] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1al, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 3:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3al, with a yield of 63%.
[0248] The chemical reaction formula for the above preparation process is as follows:
[0249]
[0250] The structural characterization data are as follows: 1 H NMR(400MHz, CDCl3)δ7.98(s,1H),7.70(d,1H),7.26(d,1H),7.08(m,2H),6.96(d, 1H),4.01-3.97(m,2H),2.91-2.81(m,2H),2.60(t,2H),1.64(t,2H),1.13(s,6H). 13 C NMR (101MHz, CDCl3) δ178.1,172.3,136.1,127.7,122.2,122.0,119.4,119.2,112.9,111.0,40.7,38.3,30.9,29.7,25.5,23.6.
[0251] Example 39
[0252] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1am, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3am, with a yield of 78%.
[0253] The chemical reaction formula for the above preparation process is as follows:
[0254]
[0255] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ5.38-5.23(m,2H),3.69-3.61(m,2H),2.62(t,J=6.8Hz,2H),2.00-1.84 (m,3H),1.71(t,J=6.8Hz,2H),1.44-1.34(m,2H),1.23-1.15(m,29H),0.81(t,J=6.7Hz,3H). 13C NMR (101MHz, CDCl3) δ178.0,172.2,129.9,129.9,40.0,38.3,31.9,31.0,29.79,29.75,29.71,29 .68,29.54,29.45,29.34,29.29,29.2,28.0,27.2,26.9,25.5,22.7,14.2.HRMS(ESI)m / z:[M+Na] + calcd for C 25 H 45 NNaO2 + :414.3343; found:414.3343.
[0256] Example 40
[0257] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1an, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3an, with a yield of 71%.
[0258] The chemical reaction formula for the above preparation process is as follows:
[0259]
[0260] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.06(d,J=8.2Hz,1H),6.89(d,J=8.1Hz,1H),6.82(s,1H),3.84(d,J=13.3Hz,1H),3.68(d,J=13.3Hz,1H),2.88-2.80(m,2H),2 .78-2.70(m,1H),2.63(s,2H),2.17(d,1H),2.08-2.00(m,1H),1.69(h,3H ),1.54(m,2H),1.33-1.18(m,7H),1.16(d,6H),1.13(d,6H),0.84(s,3H). 13C NMR (101MHz, CDCl3) δ179.1,173.1,147.5,145.5,135.0,127.0,123.9,123.7,48.6,46.5,39.4,39.0 ,38.3,37.7,37.2,33.5,30.8,30.3,30.0,25.9,24.1,24.0,19.6,18.9,18.6.HRMS(ESI)m / z:[M+Na] + calcd for C 27 H 39 NNaO2 + :432.2873; found:432.2875.
[0261] Example 41
[0262] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ao, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ao, with a yield of 87%.
[0263] The chemical reaction formula for the above preparation process is as follows:
[0264]
[0265] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.31(d,2H),7.27-7.14(m,3H),6.92(d,2H),6.82(d,2H),5.03(d,J=13.7Hz,1H),4.90(d,J=13.7Hz,1H),2.6 1-2.50(m,1H),2.39-2.35(m,1H),2.33(d,2H),2.30-2.22(m,1H),2.07-1.96(m,1H),1.79-1.68(m,1H),1.46(s,3H),0.79(d,6H). 13C NMR (101MHz, CDCl3) δ176.2,172.4,140.9,138.2,137.2,129.7,129.0,128.5,12 7.5,125.3,47.5,44.8,43.4,30.7,30.3,30.1,27.8,22.4.HRMS(ESI)m / z:[M+Na] + calcd for C 23 H 27 NNaO2 + 372.1934; found: 372.1939.
[0266] Example 42
[0267] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1ap, 0.2 mmol), phenyl acrylate (denoted as 2a, 0.8 mmol), titanium dioxide dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate in a 1:1 ratio as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 3ap, with a yield of 33%.
[0268] The chemical reaction formula for the above preparation process is as follows:
[0269]
[0270] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.29(dd,2H),7.15(dd,1H),7.04(td,1H),6.96(td,1H),5.32(s,1H),4.61(d,J=15.8Hz,1H),4.51(d,J=15.8Hz,1H),4.08-4 .02(m,2H),4.00-3.93(m,2H),3.64-3.60(m,2H),3.54(s,3H),2.68(t,J= 6.8Hz,2H),2.35(s,3H),1.78(t,J=6.8Hz,1H),1.23(d,6H),1.10(t,3H). 13C NMR (101MHz, CDCl3) δ178.6,172.6,168.2,167.2,145.9,145.3,144.6,132.3,131.5,129.2,127.3,126.8, 103.6,101.0,69.0,68.1,59.7,50.7,39.6,38.5,37.1,30.9,29.7,25.5,19.2,14.3.HRMS(ESI)m / z:[M+Na] + calcd for C 27 H 33 ClN2NaO7 + :555.1868; found:555.1868.
[0271] Example 43
[0272] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2b, 0.8 mmol), a titanium dioxide dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 4b, with a yield of 52% (88:12d.r).
[0273] The chemical reaction formula for the above preparation process is as follows:
[0274]
[0275] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.41-7.38(m,2H),7.34-7.20(m,6H),7.06-6.97(m,2H),5.11(d,J=13 .7Hz,1H),5.00(d,J=13.7Hz,1H),2.43-2.29(m,2H),1.92(t,1H),1.55(s,3H),1.24(d,3H). 13 C NMR(101MHz, CDCl3)δ176.0,175.3,141.6,137.3,129.0,129.0,128.4,127.4,127.3,125.5,48.5,43.7,39.6,34.5,28.1,16.4.HRMS(ESI)m / z:[M+Na] + calcd for C 20 H21 NNaO2 + :330.1464; found:330.1466.
[0276] Example 44
[0277] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2c, 0.8 mmol), a titanium dioxide dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 4c, with a yield of 63% (89:11 d.r).
[0278] The chemical reaction formula for the above preparation process is as follows:
[0279]
[0280] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.32-7.29(m,2H),7.22-7.12(m,6H),6.94-6.90(m,2H),5.02(d,J=13.7Hz,1H),4.92(d, J=13.7Hz,1H),2.32(q,1H),2.20-2.13(m,1H),1.86-1.78(m,2H),1.58-1.51(m,1H),1.47(s,3H),0.83(t,3H). 13 C NMR(101MHz, CDCl3)δ175.9,174.7,141.5,137.4,129.0,128.3,127.4,127.3,125.4,48.2,43.7,40.6,35.8,28.3,23.6,10.7.HRMS(ESI)m / z:[M+Na] + calcd for C 21 H 23 NNaO2 + :344.1621; found:344.1628.
[0281] Example 45
[0282] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2d, 0.8 mmol), a titanium dioxide dichlorodichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 4d, with a yield of 60% (3:1d.r).
[0283] The chemical reaction formula for the above preparation process is as follows:
[0284]
[0285] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.46-7.42(m,2H),7.33-7.24(m,9H),7.09-7.04(m,4H),5.15(d,J=13.5Hz,1H),5.06(d, J=13.5Hz,1H),3.52(dd,J=13.4,4.8Hz,1H),2.60(dd,J=14.0,4.8Hz,1H),2.41(t,J=13.7Hz,1H),1.59(s,3H). 13 C NMR (101MHz, CDCl3) δ175.7,173.5,141.1,138.8,137.2,129.4,129.2,128.8,1 28.4,127.6,127.6,125.5,48.6,46.9,44.0,39.6,28.1.HRMS(ESI)m / z:[M+Na] + calcd for C 25 H 23 NNaO2 + :392.1621; found:392.1621.
[0286] Example 46
[0287] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2e, 0.8 mmol), a titanium dioxide dichlorodichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in formula 4e, with a yield of 61% (>99:1 d.r).
[0288] The chemical reaction formula for the above preparation process is as follows:
[0289]
[0290] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.39-7.35(m,2H),7.31-7.24(m,6H),7.18(dd,3H),7.09-7.06(m,2H),6.86-6.82(m,2H),5.11(d,J=1 3.7Hz,1H),5.01(d,J=13.7Hz,1H),3.36(dd,1H),2.75(dd,1H),2.68-2.58(m,1H),2.21(dd,1H),1.78(t,1H),1.44(s,3H). 13 C NMR (101MHz, CDCl3) δ175.7,174.2,141.0,138.3,137.2,129.1,128.98,128.96,128.6,12 8.4,127.5,127.3,126.6,125.4,48.2,43.8,41.0,36.5,35.4,28.3.HRMS(ESI)m / z:[M+H] + calcd for C 26 H 26 NO2 + 384.1958; found: 384.1964.
[0291] Example 47
[0292] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2f, 0.8 mmol), a titanium dioxide dichlorodichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 4f, with a yield of 61% (7:3d.r).
[0293] The chemical reaction formula for the above preparation process is as follows:
[0294]
[0295] The structural characterization data are as follows: 1H NMR(400MHz, CDCl3)δ7.36(d,2H),7.25-7.18(m,5H),7.17-7.11(m,4H),7.09-7.06(m,2H),6 .92(d,1H),5.03(q,2H),4.11(dd,1H),2.47(q,1H),2.20(s,3H),1.99(dd,1H),1.74(d,3H). 13 C NMR (101MHz, CDCl3) δ176.8,172.8,144.1,137.5,136.7,136.0,130.8,129.2,128.6,128.5, 127.6,127.5,127.2,126.5,126.3,47.9,44.0,41.2,22.8,20.7,19.7.HRMS(ESI)m / z:[M+H] + calcd for C 26 H 26 NO2 + :384.1958; found:384.1958.
[0296] Example 48
[0297] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), substituted phenyl acrylate (denoted as 2 g, 0.8 mmol), dichlorodicyclopentadiene (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 4 g, with a yield of 61% (85:15 d.r).
[0298] The chemical reaction formula for the above preparation process is as follows:
[0299]
[0300] The structural characterization data are as follows: 1 H NMR(400MHz, CDCl3)δ7.45(d,1H),7.35(d,3H),7.26-7.16(m,8H),6.98-6.95(m,2H),5.07(d, J=13.6Hz,1H),4.98(d,J=13.6Hz,1H),3.50(dd,1H),2.51(dd,1H),2.33(t,1H),1.52(s,3H). 13C NMR (101MHz, CDCl3) δ175.4,172.8,140.9,139.6,137.0,132.1,129.4,129.3,129.3,128. 5,127.7,125.4,125.3(q),124.6(q),48.6,46.7,44.1,39.3,28.0.HRMS(ESI)m / z:[M+Na] + calcd for C 26 H 22 F3NNaO2 + :460.1495; found:460.1495.
[0301] Example 49
[0302] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2h, 0.8 mmol), a titanium dioxide dichlorodichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in formula 4h, with a yield of 65% (4:1 d.r).
[0303] The chemical reaction formula for the above preparation process is as follows:
[0304]
[0305] The structural characterization data are as follows: 1 H NMR(400MHz, CDCl3)δ7.36(d,2H),7.21-7.15(m,4H),7.14-7.09(m,2H),7.01-6.93(m,4H),6.78(d,2H),5.07(d, J=13.7Hz,1H),4.97(d,J=13.7Hz,1H),3.39(dd,1H),2.49(dd,1H),2.35-2.28(m,1H),2.21(s,3H),1.49(s,3H). 13 C NMR (101MHz, CDCl3) δ175.7,173.7,141.1,138.8,138.5,137.3,129.4,129.3,129.2, 128.8,128.5,128.4,127.6,127.6,125.5,125.4,48.6,46.9,44.1,39.5,28.1,21.5.
[0306] Example 50
[0307] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2i, 0.8 mmol), a titanium dioxide dichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in formula 4i, with a yield of 37% (1:1 d.r).
[0308] The chemical reaction formula for the above preparation process is as follows:
[0309]
[0310] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.54-7.50(m,2H),7.38-7.30(m,3H),7.25(dt,J=4.6,2.5Hz,2H),7.19-7.04(m,5H),6.89-6.80(m,1H),6.68-6.53(m,1H), 5.25-5.10(m,2H),3.64(t,J=5.3Hz,0.5H),3.37(dd,J=14.0,3.7Hz,0.5 H),2.91-2.86(m,1H),2.79-2.68(m,1H),1.66(s,1.5H),1.36(s,1.5H). 13 C NMR (101MHz, CDCl3) δ176.7,176.05,172.07,171.6,138.8,137.9,137.2,136. 9,136.6,129.9,129.7,129.4,128.9,128.6,128.5,128.42,128.38,128.01,12 7.95,127.92,127.90,127.8,127.74,127.71,127.65,127.6,127.4,125.8,52 .4,52.2,46.4,46.0,43.7,43.6,36.6,35.8,24.3,23.8.HRMS(ESI)m / z:[M+Na] + calcd for C 25 H 23 NNaO2 + :392.1621; found:392.1621.
[0311] Example 51
[0312] In a nitrogen-filled glove box, a tertiary α-haloamide compound (denoted as 1a, 0.2 mmol), a substituted phenyl acrylate (denoted as 2j, 0.8 mmol), a titanium dioxide dichlorodichlorophenoxyacetate (5.0 mg), and magnesium powder (0.4 mmol) were mixed in a 15 mL pressure-resistant tube with a magnetic stir bar and stirred at room temperature for 12 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether:ethyl acetate at a ratio of 5:1 as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in formula 4j, with a yield of 53% (46:54 d.r).
[0313] The chemical reaction formula for the above preparation process is as follows:
[0314]
[0315] The structural characterization data are as follows: 1 H NMR (400MHz, CDCl3) δ7.46-7.41(m,2H),7.35(d,J=8.1Hz,1H),7.30-7.26(m,3H),7.24-7. 10(m,3H),7.08-7.02(m,1H),6.99-6.96(m,1H),6.84(d,J=8.2Hz,2H),6.65(d,J=8.0Hz,2H ),6.53-6.49(m,1H),5.18-4.98(m,2H),3.63(t,J=5.5Hz,0.5H),3.35(dd,J=14.0,3.6Hz, 0.5H), 2.92-2.79 (m, 1.5H), 2.64 (dd, J=17.3, 3.7Hz, 0.5H), 1.58 (s, 1.5H), 1.29 (s, 1.5H). 13 CNMR(101MHz,CDCl3)δ176.1,175.7,171.4,171.0,142.74,142.65,141.0,137 .4,137.0,136.5,130.0,129.9,129.6,129.4,129.0,128.8,128.6,128.5,128. 2,128.0,127.9,127.81,127.79,127.7,125.8,125.5(q),124.7(q),115.3,52 .1,52.0,46.3,45.9,43.8,43.7,36.2,35.6,24.2,23.3.HRMS(ESI)m / z:[M+Na] + calcd for C 26 H 22 F3NNaO2 +:460.1495; found:460.1497.
[0316] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A method for preparing an N-substituted glutarimide compound, characterized in that, Includes the following steps: Under a protective atmosphere, a tertiary α-haloamide compound, an electron-withdrawing olefin, a catalyst, magnesium powder, and an organic solvent are mixed and subjected to a cyclization coupling reaction to obtain an N-substituted glutarimide compound; the catalyst includes one or more of dichlorodicyclopentadiene, CpTiCl3, and Cp*TiCl3; the temperature of the cyclization coupling reaction is ≤40℃.
2. The preparation method according to claim 1, characterized in that, The tertiary α-haloamide has the structure shown in Formula I: Among them, R 1 R 2 and R 3 Independently, it is alkyl, alkenyl, cycloalkyl, unsubstituted or substituted aryl, and X is chlorine or bromine.
3. The preparation method according to claim 2, characterized in that, The alkyl group includes C1 to C4 alkyl groups; The alkenyl group includes C4-C18 alkenyl groups; The cycloalkyl group includes C3 to C10 cycloalkyl groups; The aryl groups in the unsubstituted or substituted aryl groups include phenyl, naphthyl, tetrahydropyranyl, thiophenyl, piperidinyl, pyridinyl, furanyl, indolyl, or dehydroabiyl. The substituents in the substituted aryl group include one or more of alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, cyano, phenyl, alkylamine, alkynyl, alkenyl, and Boc protecting groups.
4. The preparation method according to claim 2 or 3, characterized in that, The R 1 Including methyl, ethyl, isopropyl, cyclobutane, cyclopentane, cycloheptane or 2-bicyclo[2.2.1]heptane; The R 2 Including methyl, phenyl, 2-methylphenyl, cyclobutane, cyclopentane, cycloheptane or 2-bicyclo[2.2.1]heptane; The R 3 This includes residues in primary amines other than -NH2; said primary amines include benzylamine, 2-(trifluoromethyl)benzylamine, o-chlorobenzylamine, o-methylbenzylamine, m-methylbenzylamine, p-trifluoromethoxybenzylamine, p-bromobenzylamine, p-chlorobenzylamine, p-cyanobenzylamine, p-phenylbenzylamine, 3,4-methylenedioxybenzylamine, alpha-methylbenzylamine, aniline, mesitylene, 2-naphthylamine, butylamine, cyclopentylmethylamine, cyclohexylmethylamine, 1-adamantanemethylamine, 4-aminotetrahydropyran, 2-thiopheneethylamine, 2-methylallylamine, cyclopropylamine, 4-ethynylaniline, 1-Boc-4-aminopiperidine, 2-amino-5-cyanopyridine, 1,3-phenylenediamine, methylamine, 2-furan-2-ylethylamine, tryptamine, oleylamine, dehydrorosinamine, naproxen, or amlodipine.
5. The preparation method according to claim 1, characterized in that, The electron-withdrawing olefins include substituted phenyl acrylates; The substituted phenyl acrylates have the structure shown in Formula II: Among them, R 4 R is an alkyl or substituted phenyl group. 5 It is a phenyl or substituted phenyl.
6. The preparation method according to claim 5, characterized in that, The alkyl group includes C1 to C4 alkyl groups; The substituents in the substituted phenyl group include methylene, methyl, or trifluoromethyl.
7. The preparation method according to claim 1, characterized in that, The molar ratio of the tertiary α-haloamide compound to the electron-withdrawing olefin is 1:1 to 3.
8. The preparation method according to claim 1, characterized in that, The molar ratio of the tertiary α-haloamide compound to the catalyst is 1:0.05 to 0.
2.
9. The preparation method according to claim 1, characterized in that, The molar ratio of the tertiary α-haloamide compound to magnesium powder is 1:1 to 3.
10. The preparation method according to any one of claims 1-3 and 5-9, characterized in that, The cyclization coupling reaction takes 3 to 24 hours.
